DAVIES JOHN E has a total of 22 patent applications. Its first patent ever was published in 1980. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are METCELA INC, TOKYO WOMEN'S MEDICAL COLLEGE and CELULARITY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Brazil | 1 | |
#8 | Malawi | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Davies John E | 21 |
#2 | Baksh Dolores | 18 |
#3 | Sarugaser Rahul | 8 |
#4 | Ennis Jane | 7 |
#5 | Lickorish Antony David Sutton | 6 |
#6 | Hosseini Morris | 6 |
#7 | Gomez-Aristiz-Abal Alejandro | 4 |
#8 | Zandstra Peter | 4 |
#9 | Rzeszutek Kathy | 2 |
#10 | Gomez-Aristizabal Alejandro | 2 |
Publication | Filing date | Title |
---|---|---|
CA2871219A1 | Immune privileged and modulatory progenitor cells | |
EP1725656A1 | Serum-free suspension culture system for mesenchymal progenitor cells | |
KR20050115862A | Progenitor cells from wharton's jelly of human umbilical cord | |
WO03045454A2 | Resorption-controlled bone implants | |
MW280A1 | Apparatus for use in the steam conditioning of tobacco |